Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Aradhana Sarin
Age : 47
Public asset : 14,252,409 USD
Country of residence : Unknown
Linked companies : AstraZeneca PLC - Achillion Pharmaceuticals, Inc.

Biography of Aradhana Sarin 
Dr. Aradhana Sarin is a President & Director at Achillion Pharmaceuticals, Inc. and a Chief Financial Officer & Executive Vice President at Alexion Pharmaceuticals, Inc. He is on the Board of Directors at Achillion Pharmaceuticals, Inc. Dr. Sarin was previously employed as an Independent Director by OraSure Technologies, Inc., a MD-Healthcare Corporate & Investment Banking by Citizens, Inc. (Austin, Texas), and a Managing Director-Healthcare Investment Banking by UBS AG. He received his MBA from Stanford Graduate School of Business.


Current positions of Aradhana Sarin 
Holdings of Aradhana Sarin 
Aradhana Sarin : Personal Network 
Most Read News 
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/09ELON MUSK : Elon Musk sells 7.92 million Tesla shares worth $6.9 billion - SEC filing
RE
08/12MASAYOSHI SON : With Alibaba stake cut, SoftBank's Son cools toward China tech
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
08/02STEPHEN KING : Horror author Stephen King says in publishing trial that consolidation hurts competition
RE
08/01STEPHEN KING : Stephen King goes to bat for U.S. gov't in case against book publishing mega-merger
RE
08/04ELON MUSK : Twitter rejects Musk's claims that he was hoodwinked
RE
10:52aANSHU JAIN : Former Deutsche Bank co-CEO Anshu Jain dies - Bloomberg News
RE
More news


© 2022 People and Ownership :   
Aradhana Sarin : Connections 


Latest news about Aradhana Sarin 
07/29TRANSCRIPT : AstraZeneca PLC, H1 2022 Earnings Call, Jul 29, 2022
CI
07/29AstraZeneca lifts revenue guidance on COVID treatment
RE
04/29TRANSCRIPT : AstraZeneca PLC - Shareholder/Analyst Call
CI
04/29TRANSCRIPT : AstraZeneca PLC, Q1 2022 Earnings Call, Apr 29, 2022
CI
02/10TRANSCRIPT : AstraZeneca PLC, 2021 Earnings Call, Feb 10, 2022
CI
2021TRANSCRIPT : AstraZeneca PLC, Q3 2021 Earnings Call, Nov 12, 2021
CI
2021TRANSCRIPT : AstraZeneca PLC, H1 2021 Earnings Call, Jul 29, 2021
CI
More news